https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-(epa)-and-a-glp-1-agonist-caused-synergistic-changes-in-protein-expression-and-mediators-of-endothelial-endoplasmic-reticulum-function-during-inflammation 2026-03-12 https://www.elucidacommunications.com/posters/high-glucose-enhanced-lipoprotein(a)-%5Blp(a)%5D-oxidation-in-a-manner-inhibited-by-eicosapentaenoic-acid-(epa)-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-(epa)-limits-lipoprotein(a)-oxidation-and-its-related-effects-on-endothelial-cell-stress-response-protein-expression 2026-03-12 https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-(epa)-inhibited-lipoprotein(a)-%5Blp(a)%5D-oxidation-and-its-effects-on-expression-of-oxidative-stress-and-pro-inflammatory-proteins-in-endothelial-cells 2026-03-12 https://www.elucidacommunications.com/posters/high-glucose-enhanced-lipoprotein(a)-%5Blp(a)%5D-oxidation-in-a-manner-inhibited-by-eicosapentaenoic-acid-(epa)-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-(epa)-and-a-high-intensity-statin-enhanced-expression-of-proteins-for-detoxification-of-reactive-oxygen-species-during-angiotensin-ii-challenge-in-endothelial-cells 2026-03-12 https://www.elucidacommunications.com/posters/inhibition-of-lipoprotein(a)-%5Blp(a)%5D-oxidation-by-atorvastatin-active-hydroxylated-metabolites-during-hyperglycemia-compared-to-rosuvastatin-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-(epa)-and-rosuvastatin-modulate-expression-of-endothelial-proteins-that-regulate-function-and-platelet-activity-during-angiotensin-ii-stimulation 2026-03-12 https://www.elucidacommunications.com/posters/atorvastatin-active-hydroxylated-metabolite-inhibits-lipoprotein(a)-%5Blp(a)%5D-oxidation-compared-to-rosuvastatin-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/sotagliflozin%2C-a-dual-sglt-1-and-2-inhibitor%2C-favorably-modulated-expression-of-glucose-transport-and-inflammatory-proteins-in-endothelial-cells-following-angiotensin-ii-stimulation 2026-03-12 https://www.elucidacommunications.com/posters/atorvastatin-active-hydroxylated-metabolites-inhibit-lipoprotein(a)-oxidation-compared-to-other-widely-used-statins 2026-03-12 https://www.elucidacommunications.com/posters/atorvastatin-active-metabolite-and-eicosapentaenoic-acid-inhibit-oxidation-of-lipoprotein(a)-%5Blp(a)%5D-in-a-synergistic-manner-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-increases-expression-of-cytoprotective-proteins-in-the-antioxidant-response-element-(are)-during-inflammation-in-endothelial-cells 2026-03-12 https://www.elucidacommunications.com/posters/atorvastatin-active-metabolite-and-eicosapentaenoic-acid-inhibit-oxidation-of-lipoprotein(a)-%5Blp(a)%5D-in-a-synergistic-manner-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-(epa)-inhibits-lipoprotein(a)-%5Blp(a)%5D-oxidation-under-normal-and-high-glucose-conditions-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/fenofibric-acid-has-distinct-molecular-location-in-reconstituted-liver-membranes-and-higher-affinity-compared-to-pemafibrate 2026-03-12 https://www.elucidacommunications.com/posters/more-rapid-oxidation-of-lipoprotein(a)-%5Blp(a)%5D-enriched-plasma-compared-to-small-dense-and-triglyceride-rich-lipoproteins-is-limited-by-eicosapentaenoic-acid-(epa) 2026-03-12 https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-(epa)-and-a-glp-1-agonist-caused-synergistic-changes-in-protein-expression-and-mediators-of-endothelial-endoplasmic-reticulum-function-during-inflammation 2026-03-12 https://www.elucidacommunications.com/posters/addition-of-eicosapentaenoic-acid-(epa)-to-a-glp-1-agonist-increased-expression-of-an-endothelial-antioxidant-response-element-(are)-protein-in-a-synergistic-fashion-during-inflammation 2026-03-12 https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-(epa)-inhibits-lipoprotein(a)-%5Blp(a)%5D-oxidation-due-to-scavenging-mechanisms-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/addition-of-eicosapentaenoic-acid-(epa)-to-a-glp-1-agonist-enhanced-expression-of-detoxification-proteins-in-endothelial-cells-during-inflammation-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/eicosapentaenoic-acid-(epa)-inhibits-lipoprotein(a)-%5Blp(a)%5D-with-higher-rates-of-oxidation-compared-to-non-modified-low-density-lipoprotein-(ldl)-in-vitro 2026-03-12 https://www.elucidacommunications.com/posters/lipoprotein(a)-%5Blp(a)%5D-enriched-plasma-undergoes-more-rapid-oxidation-than-small-dense-ldl-enriched-plasma-that-is-inhibited-by-eicosapentaenoic-acid-(epa) 2026-03-12